Profile
KdT Ventures is a venture capital firm based in Austin, Texas, founded in 2017 by Cain McClary. The firm focuses on early-stage investments in frontier science, particularly at the intersection of technology and science. The team, comprising professionals with backgrounds in science, engineering, and computation, is dedicated to supporting founders who are engineering the future at its deepest layers.
KdT Ventures invests primarily in sectors such as biotechnology, chemistry, and materials, with a particular interest in companies that commercialize science to rewire the physical layer of the world. They typically write first institutional checks ranging from $500K to $5M, focusing on pre-seed and seed rounds. The firm manages several funds, including KdT Ventures Fund I, II, and III, with a total AUM of over $145 million.
Notable portfolio companies include Tacit Therapeutics - drug discovery, Skeletalis - drug discovery, Zag Bio - drug delivery, Faeth - drug discovery, and Character Biosciences - drug discovery. These investments reflect KdT's commitment to backing transformative science-driven ventures.
Industry
KdT Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
KdT Ventures Fund I
|
Venture Capital (VC)
|
Education
Financial Services
Fintech
Food and Beverage
Foodtech
Robotics
SaaS
Security
Software
Energy
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$15 M
|
March 2018
|
|
KdT Ventures Fund II
|
Venture Capital (VC)
|
Education
Healthcare Services
Robotics
SaaS
Security
Software
Energy
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$50 M
|
March 2021
|
|
KdT Ventures Fund III
|
Venture Capital (VC)
|
Financial Services
Fintech
Healthcare Services
Robotics
SaaS
Security
Software
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$80 M
|
January 2022
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.